InvestorsHub Logo
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

Re: None

Friday, 07/27/2018 2:46:06 PM

Friday, July 27, 2018 2:46:06 PM

Post# of 1721
INSYS Therapeutics Receives Complete Response Letter from FDA for Buprenorphine NDA

https://tinyurl.com/yb4x7m7w

As predicted here, the FDA politicos refused to approve Insys' better format of a long-approved drug for treating addiction.

Best, Terry

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.